Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0267964 (
PAA
)
2,561
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Cerebrospinal fluid levels of phenylacetic acid (CSF
PAA
) were obtained from normal controls and from drug-free psychiatric inpatients (schizophrenia, major depression,
mania
, and schizoaffective disorder). Post-treatment CSF
PAA
levels were obtained from 16 patients after 4 weeks of neuroleptic treatment. Phenylacetic acid levels were higher in women and were significantly correlated with age. There were no differences in CSF
PAA
levels between the various diagnostic groups and no difference between the paranoid and the nonparanoid subtypes of schizophrenia. CSF
PAA
was significantly correlated with several measures of psychopathology, especially the Brief Psychiatric Rating Scale hostility/suspiciousness factor. Neuroleptic treatment did not result in significant
PAA
changes. These findings are discussed in light of the amphetamine-like role ascribed to phenylethylamine, the precursor of
PAA
.
...
PMID:Cerebrospinal fluid levels of phenylacetic acid in mental illness: behavioral associations and response to neuroleptic treatment. 763 84